Beijing’s Quiet April: How Two State Council Decrees Are Reshaping Cross-Border Investment into China

Decrees 834 and 835 don’t change the headline on China’s open-door policy. They change the floor beneath it.

If you only read the political readouts, China’s foreign investment posture in 2026 looks much like it did in 2025. The 2026 Negative List is being narrowed again, the Encouraged Industries Catalogue was expanded in February, and MOFCOM continues to publish polite, English-friendly statements about deepening opening-up. The rhetoric is steady.

But the rule changes underneath are not.

In the second week of April, the State Council issued two decrees within six days of each other — Decree №834 on Industrial and Supply Chain Security on 7 April, and Decree №835 on Countering Foreign Improper Extraterritorial Jurisdiction on 13 April. Both took effect immediately. Neither came with a transition period. For multinationals operating in or selling into China, and for Chinese groups that depend on foreign technology, capital, or counterparties, the practical compliance map of the country has been redrawn.

This piece is an attempt to put the two regulations in one frame, and to think about what they mean for the deals and structures we actually work on.

What the two decrees actually do

Decree 834 — Supply Chain Security. The regulation gives the State Council an explicit mandate to assess, monitor, and intervene in industrial and supply chain risks across sectors deemed strategically important. It pairs ex ante review (assessments of vulnerabilities in inputs, technology dependencies, and offshore single points of failure) with ex post tools (the ability to order changes in sourcing, inventory, or transactional behavior when a perceived risk crystallises). Critically, the obligations attach not only to state-owned enterprises but to private and foreign-invested entities whose activities are deemed to affect the security of a relevant chain.

Decree 835 — Counter-Extraterritorial Jurisdiction.** This is more often described in the press as China’s upgraded “blocking statute,” but the framing undersells it. The 2021 MOFCOM Blocking Rules were essentially defensive — a process to seek exemptions from, and damages for, foreign sanctions found “unjustified.” Decree 835 adds three new edges. First, prohibition orders against compliance with designated foreign measures, with administrative consequences for the Chinese entity that complies anyway. Second, a “malicious actors” or “improper enforcement” list, with the verb “promote” (推动) deliberately broad enough to capture advisors, intermediaries, and group affiliates. Third, an explicit reference in Article 12 to potential criminal liability — a meaningful escalation from the purely administrative posture of the 2021 instrument.

Read together, the two decrees are best understood as one project: a tighter, more proactive economic security regime that operates alongside, not in place of, the inbound investment framework.

Why the timing matters

Decrees 834 and 835 did not arrive in isolation. They sit on top of the revised Foreign Trade Law (in force 1 March 2026), the new Commercial Mediation Regulation (1 May 2026), and the April 2026 NDRC decision unwinding the Meta–Manus AI transaction — the first time China has used its Foreign Investment Security Review Mechanism to reverse a closed deal. Each of these instruments individually is significant. Layered, they describe a regulator that is willing to look through legal form, willing to act after closing, and increasingly comfortable with extraterritorial reach of its own.

For investors, that combination matters more than any single article in any single decree. Risk used to crystallise primarily at filing or at clearance. Now it lives across the full life of the asset.

A legal and transactional view

For the cross-border M&A practitioner, several practical consequences follow.

First, security review is now bilateral and persistent. A deal touching China-origin technology can attract scrutiny under U.S. outbound-investment rules, under the EU’s FSR or member-state FDI regimes, and — as Meta–Manus made clear — under China’s own security review even after the transaction has closed and been integrated. Conditions precedent need to be drafted with the assumption that all three regimes can move in parallel and unpredictably.

Second, the relocation playbook needs to be reassessed. For years, the standard response to perceived China risk has been to set up an offshore parent, relocate the team to Singapore or Dubai, and ring-fence the IP. Decree 835 implicitly, and the Manus decision explicitly, signal that Beijing is prepared to assess the substance of a company’s connection to China — founders, R&D base, training data, supply chain dependencies — rather than the location of its holding entity. Redomicile remains a legitimate planning tool. As a defensive shield against Chinese review, it has become noticeably thinner.

Third, contract drafting has to absorb genuine “compliance conflict” risk. A Chinese subsidiary may now be told, by prohibition order, not to comply with a foreign sanctions instruction that the global group is otherwise honouring. Material adverse change, force majeure, and compliance-with-laws clauses written for a more orderly regulatory world need to be rewritten with that scenario actually in mind, rather than assumed away.

Fourth, due diligence has to widen. Standard supply-chain diligence on a target now needs to consider not only third-country export controls and human-rights screening but also whether the target — or any of its critical inputs — sits inside what Decree 834 might call a “key” chain. That assessment is easier to do before signing than after.

What this means for Chinese groups and inbound investors

For Chinese groups investing outbound, the takeaway is less about new prohibitions than about new visibility. Domestic regulators now have a clearer statutory basis to ask what foreign measures a transaction would expose the group to, and to instruct against compliance with those measures if necessary. Outbound deal teams should expect those questions earlier in the approval cycle — and should have answers prepared.

For foreign investors coming into China, the message is more nuanced. The headline policy is unchanged: the manufacturing negative list is essentially open, services pilots are widening, and the Encouraged Industries Catalogue is more generous than it was. The floor, however, is firmer. Operating in China increasingly comes with embedded obligations — supply chain transparency, data localisation, sanctions-conflict management — that are best treated as part of the deal economics, not as a post-signing afterthought.

For Belt and Road and third-country joint ventures, Decree 835 is particularly worth watching. If a Chinese partner is instructed not to comply with a Western secondary sanction, the joint venture’s contractual cure provisions, dispute resolution clauses, and governing law choices may all be tested in ways they were drafted to avoid.

A measured conclusion

It is tempting to read every new Chinese regulation as either an opening or a closing. April 2026 was neither. It was a clarification. Beijing has stated, in two crisp documents, what it considers fair game for proactive intervention and what kinds of foreign legal orders it will not accept as binding on its territory.

The companies and counsel that adjust quietly — by widening diligence, redrafting conflict-of-laws and sanctions clauses, and rebuilding internal escalation processes — will find that cross-border investment in China remains viable, sometimes very attractive. Those who assume that the policy speeches in Beijing fully describe the operating environment may find themselves negotiating from a weaker position than the headlines suggested.

The author is a cross-border investment lawyer at DeHeng Law Offices. Views are personal and do not constitute legal advice.